Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enlivex Therapeutics Ltd. Share Issue/Capital Change 2025

Nov 24, 2025

6778_rns_2025-11-24_f744e7b5-84c5-42e8-ab66-d4967e7c39bc.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

November 24, 2025 462426

To: TASE Members

Dear Sir/Madam,

Re:Enlivex Therapeutics Ltd.

The company's announcement regarding \$212,000,000 Private Placement was published abroad.

Sincerely

)-(

Listing companies compliance unit